qCT Lung Cancer

CE & Health Canada | Cardiothoracic | CT | Amplifier Partner

Amplifier Marketplace Radiology

Description of use

qCT-Lung Cancer is an AI tool designed for the early detection of lung cancer and the management of lung nodules on chest CT scans. The output provides indicators for detected lung nodules ranging in size from 3mm to 30mm. Key findings include volumetry, diameter, localization, texture, calcification, spiculation, malignancy risk, and progression monitoring/volume doubling time. The AI is adaptable and supports manual modifications.

This tool aims to assist radiologists, pulmonologists, and clinicians in the swift and precise diagnosis of nodules, optimizing time efficiency for both professionals and patients.

Benefits of using the qCT :

  • Enhance clinical diagnosis accuracy with superior sensitivity and specificity, facilitating early-stage patient identification.
  • Strengthen the safety net and minimize errors from missed reporting.
  • Eliminate the need to laboriously open two scans side by side, orient them, and measure. The AI significantly reduces time by efficiently tracking all nodules.

How is the application integrated?

Can the end-user read the results in IDS7: Yes

DICOM output: DICOM SC, Encapsulated PDF, DICOM GSPS,

Worklist integration: Yes

Pre-populated reports: Yes

Ask your Sectra representative which version of the Sectra PACS is compatible with the highlighted integration standards.

Contact us

Referring articles

The below are peer-reviewed articles that have been submitted by the AI vendor to serve as scientific validation of the application.

Other applications by this vendor

qXR Lung Cancer
CE & Health Canada | X-ray
Incidental detection of lung cancer through the identification of lung nodules between 6mm to 30mm including detection and visualization of pulmonary nodules and masses, assigning malignancy scores, and providing pre-populated reports.
qXR Heart Failure
FDA, CE & Health Canada | X-ray
Identifying high-risk heart failure patients from incidental pathways for opportunistic screening by detecting pleural effusion, cardiomegaly and assessing cardiothoracic ratio.
qXR Rad-assist
FDA, CE & Health Canada | X-ray
Segregation of worklists as unremarkable and remarkable across 40+ findings within lungs, pleura, mediastinum, bones, diaphragm, and heart along with an automated editable radiological report significantly reducing time to diagnosis and enabling early detection.
qXR Emergency Room
FDA, CE & Health Canada | X-ray
Abnormal, Atelectasis, Non Aortic Calcification, Cardiomegaly, Cavity, Consolidation, Hyper Inflation, Fibrosis, Opacity, Pleural Effusion, Prominence in Hilar Region, Reticulonodular Pattern, Scoliosis, Tracheal shift, Nodule, Pneumothorax
qER Neurosuite
FDA, CE & Health Canada | CT
Neurosuite timely cares for stroke, traumatic brain injury & injury quantification by detecting and localize up to 12+ abnormalities including ICH and subtypes, midline shift, mass effect, cranial fractures, hypodensities suggesting an Infarct + ASPECTS scoring and cerebral atrophy.

Let’s talk

Are you interested in learning more? Please do not hesitate to get in touch with us at Sectra.

Contact us

The application content is provided by the respective AI vendors.